{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04223752",
            "orgStudyIdInfo": {
                "id": "7625A-036"
            },
            "secondaryIdInfos": [
                {
                    "id": "MK-7625A-036",
                    "type": "OTHER",
                    "domain": "Merck Protocol Number"
                },
                {
                    "id": "2022-501110-56-00",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                },
                {
                    "id": "2018-004704-19",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)",
            "officialTitle": "A Phase 1, Open-label, Non-comparative, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ceftolozane/Tazobactam (MK-7625A) in Pediatric Participants With Nosocomial Pneumonia",
            "therapeuticArea": [
                "Respiratory"
            ],
            "study": "safety-and-pharmacokinetics-of-ceftolozane-tazobactam-in-pediatric-participants-with-nosocomial-pneumonia-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-04-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09-22",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-01-08",
            "studyFirstSubmitQcDate": "2020-01-08",
            "studyFirstPostDateStruct": {
                "date": "2020-01-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia (NP)."
        },
        "conditionsModule": {
            "conditions": [
                "Nosocomial Pneumonia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group 1: Ceftolozane/Tazobactam 12 to <18 Years of Age",
                    "type": "EXPERIMENTAL",
                    "description": "Participants 12 to \\<18 years of age with nosocomial pneumonia receive intravenous (IV) ceftolozane/tazobactam every 8 hours for 8-14 days.",
                    "interventionNames": [
                        "Drug: Ceftolozane/Tazobactam"
                    ]
                },
                {
                    "label": "Group 2: Ceftolozane/Tazobactam 7 to <12 Years of Age",
                    "type": "EXPERIMENTAL",
                    "description": "Participants 7 to \\<12 years of age with nosocomial pneumonia receive IV ceftolozane/tazobactam every 8 hours for 8-14 days.",
                    "interventionNames": [
                        "Drug: Ceftolozane/Tazobactam"
                    ]
                },
                {
                    "label": "Group 3: Ceftolozane/Tazobactam 2 to <7 Years of Age",
                    "type": "EXPERIMENTAL",
                    "description": "Participants 2 to \\<7 years of age with nosocomial pneumonia receive IV ceftolozane/tazobactam every 8 hours for 8-14 days.",
                    "interventionNames": [
                        "Drug: Ceftolozane/Tazobactam"
                    ]
                },
                {
                    "label": "Group 4: Ceftolozane/Tazobactam 3 Months to <2 Years of Age",
                    "type": "EXPERIMENTAL",
                    "description": "Participants 3 months to \\<2 years of age with nosocomial pneumonia receive IV ceftolozane/tazobactam every 8 hours for 8-14 days.",
                    "interventionNames": [
                        "Drug: Ceftolozane/Tazobactam"
                    ]
                },
                {
                    "label": "Group 5: Ceftolozane/Tazobactam Birth to <3 Months of Age",
                    "type": "EXPERIMENTAL",
                    "description": "Participants from birth to \\<3 months of age with nosocomial pneumonia receive IV ceftolozane/tazobactam every 8 hours for 8-14 days.",
                    "interventionNames": [
                        "Drug: Ceftolozane/Tazobactam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ceftolozane/Tazobactam",
                    "description": "Participants 12 to \\<18 years of age: IV ceftolozane 2 g with tazobactam 1 g infused over a 60-minute period.\n\nParticipants \\<12 years of age: IV ceftolozane 40 mg/kg with tazobactam 20 mg/kg infused over a 60-minute period (not to exceed a dose of ceftolozane 2g and tazobactam 1 g).",
                    "armGroupLabels": [
                        "Group 1: Ceftolozane/Tazobactam 12 to <18 Years of Age",
                        "Group 2: Ceftolozane/Tazobactam 7 to <12 Years of Age",
                        "Group 3: Ceftolozane/Tazobactam 2 to <7 Years of Age",
                        "Group 4: Ceftolozane/Tazobactam 3 Months to <2 Years of Age",
                        "Group 5: Ceftolozane/Tazobactam Birth to <3 Months of Age"
                    ],
                    "otherNames": [
                        "MK-7625A"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of participants with any adverse events (AEs)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to 31 days"
                },
                {
                    "measure": "Percentage of participants with any serious AEs (SAEs)",
                    "description": "An SAE is any untoward medical consequence that, at any dose, results in death, is life-threatening, requires inpatient hospitalization or prolongs existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or any other important medical event.",
                    "timeFrame": "Up to 31 days"
                },
                {
                    "measure": "Percentage of participants with any drug-related AEs",
                    "description": "A drug-related AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, and considered related to the study intervention.",
                    "timeFrame": "Up to 31 days"
                },
                {
                    "measure": "Percentage of participants with any drug-related SAEs",
                    "description": "A drug-related SAE is any untoward medical consequence that, at any dose, results in death, is life-threatening, requires inpatient hospitalization or prolongs existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or any other important medical event, that is considered related to the study intervention.",
                    "timeFrame": "Up to 31 days"
                },
                {
                    "measure": "Percentage of participants with AEs leading to discontinuation of study intervention",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to 14 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma concentrations of ceftolozane",
                    "description": "The plasma concentrations of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Area under the concentration-time curve of an 8-hour dosing interval (AUC0-8) of plasma ceftolozane",
                    "description": "The plasma AUC0-8 of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Area under the concentration-time curve of an 8-hour dosing interval (AUC0-8) of plasma tazobactam",
                    "description": "The plasma AUC0-8 of tazobactam will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Maximum observed concentration during a dosage interval (Cmax) of plasma ceftolozane",
                    "description": "The plasma Cmax of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Maximum observed concentration during a dosage interval (Cmax) of plasma tazobactam",
                    "description": "The plasma Cmax of tazobactam will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Elimination half-life (t1/2) of plasma ceftolozane",
                    "description": "The plasma t1/2 of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Elimination half-life (t1/2) of plasma tazobactam",
                    "description": "The plasma t1/2 of tazobactam will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Volume of distribution (Vd) of plasma ceftolozane",
                    "description": "The plasma Vd of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Volume of distribution (Vd) of plasma tazobactam",
                    "description": "The plasma Vd of tazobactam will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Clearance (CL) of plasma ceftolozane",
                    "description": "The plasma CL of ceftolozane will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                },
                {
                    "measure": "Clearance (CL) of plasma tazobactam",
                    "description": "The plasma CL of tazobactam will be determined in each group.",
                    "timeFrame": "Day 3: 1, between 4-5, and between 7-8 hours after start of infusion"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Is hospitalized and anticipated to receive a minimum of 8 days of concomitant standard-of-care \\[SOC\\] antibiotic therapy for proven or suspected NP.\n* If male, is abstinent from heterosexual intercourse, or agrees to use contraception during the intervention period and for \u226530 days after the last dose of study intervention.\n* If female, is not pregnant or breastfeeding, or is not a woman of childbearing potential (WOCBP), or is a WOCBP using acceptable contraception, is a WOCBP with negative urine or serum pregnancy test within 48 hours of the first dose of study intervention, or is abstinent from heterosexual intercourse.\n\nExclusion Criteria:\n\n* Has a documented history of any moderate or severe hypersensitivity (or allergic) reaction to any \u03b2-lactam antibacterial.\n* Participants 3 months to \\<18 years of age: has moderate to severe impairment of renal function, defined as an estimated creatinine clearance (CrCL) \\<50 mL/min/1.73 m2 based on the revised Schwartz equation or requirement for peritoneal dialysis, hemodialysis, or hemofiltration.\n* Participants \\<3 months of age: has CrCL \\<20 mL/min/1.73 m2 based on the revised Schwartz equation or requirement for peritoneal dialysis, hemodialysis, or hemofiltration.\n* Is receiving or is anticipated to receive piperacillin/tazobactam while receiving ceftolozane/tazobactam or has received piperacillin/tazobactam within 24 hours prior to the first dose of ceftolozane/tazobactam.\n* Has participated in any clinical study of a therapeutic investigational product within 30 days prior to the first dose of ceftolozane/tazobactam.\n* Has previous participation in any study of ceftolozane or ceftolozane/tazobactam.\n* Has any condition or circumstance that, in the opinion of the investigator, would compromise the safety of the participant or the quality of study data.\n* Has any rapidly progressing disease or immediately life-threatening illness including acute hepatic failure or septic shock.\n* Has active immunosuppression.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "7 Days",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "AdventHealth Orlando ( Site 1318)",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32803",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "407-821-3691"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Mayo Clinic in Rochester, Minnesota ( Site 1322)",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55902",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "720-431-3003"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Montefiore Medical Center [Bronx, NY] ( Site 1313)",
                    "status": "COMPLETED",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10467",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Sanford Children's Hospital ( Site 1301)",
                    "status": "COMPLETED",
                    "city": "Sioux Falls",
                    "state": "South Dakota",
                    "zip": "57105",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.54997,
                        "lon": -96.70033
                    }
                },
                {
                    "facility": "West Virginia University ( Site 1310)",
                    "status": "COMPLETED",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                },
                {
                    "facility": "Children's Wisconsin ( Site 1321)",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "414-337-7070"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Hospital Roberto del R\u00edo ( Site 1400)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8380418",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "992360000"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Hospital General de Medellin ( Site 1503)",
                    "status": "RECRUITING",
                    "city": "Medellin",
                    "state": "Antioquia",
                    "zip": "0500515",
                    "country": "Colombia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5743847300"
                        }
                    ],
                    "geoPoint": {
                        "lat": 6.25184,
                        "lon": -75.56359
                    }
                },
                {
                    "facility": "Ciensalud Ips S A S ( Site 1501)",
                    "status": "RECRUITING",
                    "city": "Barranquilla",
                    "state": "Atlantico",
                    "zip": "08001",
                    "country": "Colombia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "57 3183894721"
                        }
                    ],
                    "geoPoint": {
                        "lat": 10.96854,
                        "lon": -74.78132
                    }
                },
                {
                    "facility": "Clinica de la Costa S.A.S. ( Site 1500)",
                    "status": "RECRUITING",
                    "city": "Barranquilla",
                    "state": "Atlantico",
                    "zip": "080020",
                    "country": "Colombia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "3116438539"
                        }
                    ],
                    "geoPoint": {
                        "lat": 10.96854,
                        "lon": -74.78132
                    }
                },
                {
                    "facility": "Oncom\u00e9dica S.A.S ( Site 1506)",
                    "status": "RECRUITING",
                    "city": "Monter\u00eda",
                    "state": "Cordoba",
                    "zip": "230002",
                    "country": "Colombia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+57 (604) 7862333"
                        }
                    ],
                    "geoPoint": {
                        "lat": 8.74798,
                        "lon": -75.88143
                    }
                },
                {
                    "facility": "SA Tallinna Lastehaigla/Tallinn Children's Hospital ( Site 0201)",
                    "status": "RECRUITING",
                    "city": "Tallinn",
                    "state": "Harjumaa",
                    "zip": "13419",
                    "country": "Estonia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3726977122"
                        }
                    ],
                    "geoPoint": {
                        "lat": 59.43696,
                        "lon": 24.75353
                    }
                },
                {
                    "facility": "SA Tartu Ulikooli Kliinikum Lastekliinik ( Site 0200)",
                    "status": "RECRUITING",
                    "city": "Tartu",
                    "state": "Tartumaa",
                    "zip": "50406",
                    "country": "Estonia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3727319550"
                        }
                    ],
                    "geoPoint": {
                        "lat": 58.38062,
                        "lon": 26.72509
                    }
                },
                {
                    "facility": "Hippokration General Hospital of Thessaloniki ( Site 0400)",
                    "status": "RECRUITING",
                    "city": "Thessaloniki",
                    "state": "Kentriki Makedonia",
                    "zip": "546 42",
                    "country": "Greece",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+306937442644"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.64361,
                        "lon": 22.93086
                    }
                },
                {
                    "facility": "Instituto Nacional de Pediatria-Unidad de Apoyo a la Investigaci\u00f3n Cl\u00ednica ( Site 1602)",
                    "status": "RECRUITING",
                    "city": "Mexico City",
                    "state": "Distrito Federal",
                    "zip": "04530",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5525600809"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Hospital Infantil de Mexico Federico Gomez-Infectious Diseases ( Site 1600)",
                    "status": "RECRUITING",
                    "city": "Mexico City",
                    "state": "Distrito Federal",
                    "zip": "06720",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "525539391946"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Morozovskaya Children City Clinical Hospital ( Site 0901)",
                    "status": "COMPLETED",
                    "city": "Moscow",
                    "state": "Moskva",
                    "zip": "119049",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "St. Olga Children City Hospital ( Site 0906)",
                    "status": "COMPLETED",
                    "city": "Saint-Petersburg",
                    "state": "Sankt-Peterburg",
                    "zip": "194156",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Smolensk Regional Clinical Hospital ( Site 0903)",
                    "status": "COMPLETED",
                    "city": "Smolensk",
                    "state": "Smolenskaya Oblast",
                    "zip": "214018",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 54.7818,
                        "lon": 32.0401
                    }
                },
                {
                    "facility": "Hospital Universitario Sant Joan de Deu ( Site 1100)",
                    "status": "RECRUITING",
                    "city": "Esplugues de Llobregat",
                    "state": "Barcelona",
                    "zip": "08950",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+34932532100"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.37732,
                        "lon": 2.08809
                    }
                },
                {
                    "facility": "SI Dnipropetrovsk Regional Children Clinical Hospital DOR ( Site 1205)",
                    "status": "RECRUITING",
                    "city": "Dnipro",
                    "state": "Dnipropetrovska Oblast",
                    "zip": "49100",
                    "country": "Ukraine",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+380509142649"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.4593,
                        "lon": 35.03864
                    }
                },
                {
                    "facility": "Ivano-Frankivsk Regional Children Clinical Hospital ( Site 1204)",
                    "status": "RECRUITING",
                    "city": "Ivano-Frankivsk",
                    "state": "Ivano-Frankivska Oblast",
                    "zip": "76018",
                    "country": "Ukraine",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+380681040592"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.9215,
                        "lon": 24.70972
                    }
                },
                {
                    "facility": "Kharkiv City Children Hospital 16 ( Site 1200)",
                    "status": "SUSPENDED",
                    "city": "Kharkiv",
                    "state": "Kharkivska Oblast",
                    "zip": "61075",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 49.98081,
                        "lon": 36.25272
                    }
                },
                {
                    "facility": "Institution of Pediatr Obstetr and Gynec NAMS of Ukraine ( Site 1203)",
                    "status": "COMPLETED",
                    "city": "Kyiv",
                    "state": "Kyivska Oblast",
                    "zip": "04050",
                    "country": "Ukraine",
                    "geoPoint": {
                        "lat": 50.45466,
                        "lon": 30.5238
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=7625A-036&&kw=7625A-036"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011014",
                    "term": "Pneumonia"
                },
                {
                    "id": "D000077299",
                    "term": "Healthcare-Associated Pneumonia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000003428",
                    "term": "Cross Infection"
                },
                {
                    "id": "D000007049",
                    "term": "Iatrogenic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "asFound": "Pneumonia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1752",
                    "name": "Healthcare-Associated Pneumonia",
                    "asFound": "Nosocomial Pneumonia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6642",
                    "name": "Cross Infection",
                    "relevance": "LOW"
                },
                {
                    "id": "M10099",
                    "name": "Iatrogenic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T4202",
                    "name": "Oculocerebral Syndrome With Hypopigmentation",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000078142",
                    "term": "Tazobactam"
                },
                {
                    "id": "C000519491",
                    "term": "Ceftolozane"
                },
                {
                    "id": "C000594038",
                    "term": "Ceftolozane, tazobactam drug combination"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000065093",
                    "term": "beta-Lactamase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000892",
                    "term": "Anti-Infective Agents, Urinary"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1938",
                    "name": "Tazobactam",
                    "asFound": "Interferon alfa-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M261814",
                    "name": "Ceftolozane",
                    "asFound": "Reset",
                    "relevance": "HIGH"
                },
                {
                    "id": "M255449",
                    "name": "Ceftolozane, tazobactam drug combination",
                    "asFound": "Metronome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M30450",
                    "name": "beta-Lactamase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}